Published on
For decades, doctors and researchers have been working diligently to discover new treatments and provide more options for patients with Duchenne muscular dystrophy (DMD), a debilitating genetic disease that ravages the muscles in the body and leads to a loss of movement and coordination.
Published on
Agenesis of the corpus callosum (ACC) is one of the most common referrals seen in the prenatal period at the Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) at Children’s Hospital of Philadelphia (CHOP).
Published on
Dravet syndrome is a severe neurodevelopmental disorder defined by treatment-resistant epilepsy and features related to autism spectrum disorder.
Published on
Children’s Hospital of Philadelphia hosted The Runway, presented by the Jacovini Family, a contemporary lunchtime fashion show at the Mann Center curated by top Philadelphia-area boutiques and designers with proceeds benefitting CHOP’s Neuroscience Center. This year, more than $845,000 was raised!
Published on
The Movement Disorders Program is one of the only programs of its kind in the country and provides life-changing results.
Published on
Patients with this complex neurological disorder experience a wide variety of symptoms, which can be managed with early and proper diagnosis.
Published on
STXBP1-related disorders include gastrointestional and respiratory symptoms in certain patients, according to extensive interviews with caregivers.
Published on
A $25 million gift from an anonymous donor to Penn Medicine and Children’s Hospital of Philadelphia (CHOP) will establish the Center for Epilepsy and Neurodevelopmental Disorders (ENDD), accelerating collaborative research in genetic therapies for neurodevelopmental disorders.
Published on
Founded in 2005, the Pediatric Multiple Sclerosis and Neuroinflammatory Disorders Clinic at CHOP is recognized as a Partner in MS Care – Center for Comprehensive Care by the National Multiple Sclerosis Society.
Published on
The Neuroscience Center prioritizes partnered care relationships that maximize expertise, access to novel therapies, and local care.